Valeant Pharmaceuticals Acquires Ambi Skin Care

Contact Author
Close
Fill out my online form.

Skin care brand Ambi is transitioning from one parent company to another. Johnson & Johnson has sold the Ambi brand to Valeant Pharmaceuticals North America. Valeant is a multinational, 17 billion market cap pharmaceutical/OTC company based in Bridgewater, New Jersey. It also owns beauty brand Kinerase, AcneFree, CeraVe and more, in addition to multiple derm brands and other pharmaceutical product brands.

Related Content